BioElectronics Corporation
BIEL
$0.0002
$0.0001100.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 12/31/2021 | 09/30/2021 | ||||
|---|---|---|---|---|---|
| Revenue | -56.06% | 0.51% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -56.06% | 0.51% | |||
| Cost of Revenue | 13.06% | -36.38% | |||
| Gross Profit | -88.23% | 37.65% | |||
| SG&A Expenses | -107.85% | 43.60% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -47.10% | -4.19% | |||
| Operating Income | -531.25% | 76.12% | |||
| Income Before Tax | -670.09% | 148.70% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -670.09% | 148.70% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -670.09% | 148.70% | |||
| EBIT | -531.25% | 76.12% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -- | -- | |||
| Normalized Basic EPS | -- | -- | |||
| EPS Diluted | -- | -- | |||
| Normalized Diluted EPS | -- | -- | |||
| Average Basic Shares Outstanding | 1.61% | 0.00% | |||
| Average Diluted Shares Outstanding | 1.61% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
